Ulcerative Colitis

“It was remarkable: the inflammation went down, and they stopped experiencing pain and diarrhoea,” says Professor George Macfarlane, whose results were published in January.

“We did not think it would be as effective as it was.” He is now looking for funding for a more detailed trial, but neither the drug companies nor the Government are interested.

“It's an area that urgently needs to be looked into: there are people out there with distressing conditions like colitis, Crohn's disease and even arthritis that may be helped one day.

“The biggest problem is that we don't know what these things are capable of.

We go into our health food shop and buy lactobacillus and it may work or it may not.

It's a case of suck it and see at the moment until bigger trials are carried out.” In a round-up last October of all the trials so far, the Drug and Therapeutics Bulletin could only conclude that they were inconclusive.

Researchers looked at “Frankly, the studies are not that great,” says associate editor Helen Barnett.

“With irritable bowel syndrome, for example, we found five studies, but so...

So the nutrition you get out of your food is much less and because of the bleeding you lose a lot of blood and you lose bowel control.

So I basically ran around for a year and a half wearing diapers, and bleeding and being anaemic.

But it's something that was a huge character builder, when you can walk around the racetrack and still perform wearing diapers and have self dignity, it's something you have to learn.

And I think it's something that's, for sure, helped in my personality today.

So I was also very lucky with this disease because I was really one month away of having to remove my colon, and if I did that then the racing career was over.

And I was very lucky to find a doctor in Vienna, who is, you know, into some cutting-edge treatment for the disease.

And I'm very happy to say that I haven't had any symptoms or any problems with the disease for over a year.

Q.

Hey, Scott.

One last one for me and I know this probably not the question that you want to hear, because I'm sure you've heard it a million times, but is this year the last year that Formula One can get it right here in the United States?

I mean, after what happened last year, do you think the fans will come back?

Speed: I hope they come back.

I mean what happened in Indianapolis was very unfortunate and very unlucky.

But I think at the end of t...

REMICADE is the only biologic indicated for the treatment of patients with moderately-to-severely active CD who have had an inadequate response to conventional therapy.

REMICADE is also indicated for reducing the number of draining enterocutaneous and rectovaginal fistulas and maintaining fistula closure in patients with fistulizing CD.

In December 2004, REMICADE was approved for reducing signs and symptoms in patients with active AS.

In May 2005, REMICADE was approved for reducing signs and symptoms of active arthritis in patients with PsA.

Additionally, in September 2005, REMICADE was approved for reducing signs and symptoms, achieving clinical remission and mucosal healing, and eliminating corticosteroid use in patients with moderately-to-severely active UC who have had an inadequate response to conventional therapy.

This approval makes REMICADE the first and only biologic approved for the treatment of moderate to severe UC.REMICADE is unique among available anti-TNF biologic therapies.

Unlike self...